| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Dale L Greiner | |
| John P Mordes | |||
| Aldo A Rossini | |||
| Edward Seung | |||
| P2860 | cites work | Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance | Q57202280 |
| Cutting Edge: Persistent Viral Infection Prevents Tolerance Induction and Escapes Immune Control Following CD28/CD40 Blockade-Based Regimen | Q58194512 | ||
| IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo | Q60700622 | ||
| Defective CD8+ T Cell Peripheral Tolerance in Nonobese Diabetic Mice | Q61140426 | ||
| Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes | Q70419845 | ||
| Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice | Q71968128 | ||
| Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease | Q73101619 | ||
| Prolonged survival of allogeneic islet grafts in NOD mice treated with a combination of anti-CD45RB and anti-CD154 antibodies | Q73667529 | ||
| Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning | Q73910639 | ||
| Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms | Q74261355 | ||
| New developments in pancreas and islet transplantation | Q77370084 | ||
| Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice | Q78719270 | ||
| CD40 AND CD154 IN CELL-MEDIATED IMMUNITY | Q22255634 | ||
| Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 | ||
| Successful islet transplantation: continued insulin reserve provides long-term glycemic control | Q31089312 | ||
| Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death | Q31838891 | ||
| Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody | Q33798639 | ||
| Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. | Q33853487 | ||
| Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection | Q33903407 | ||
| Tolerance and hematopoietic stem cell transplantation 50 years after Burnet's theory | Q33919388 | ||
| Regulatory T cells: key controllers of immunologic self-tolerance | Q33941140 | ||
| Noncompliance in organ transplant recipients: a literature review | Q34079538 | ||
| Human islet cell transplantation--future prospects | Q34184785 | ||
| Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy | Q34231811 | ||
| Mixed chimerism and transplant tolerance | Q34241143 | ||
| Impact of bone marrow transplantation on type I diabetes | Q34245819 | ||
| Pancreas transplantation for treatment of diabetes mellitus | Q34245831 | ||
| The lost chord: microchimerism and allograft survival | Q34359678 | ||
| Controlling the incidence of infection and malignancy by modifying immunosuppression | Q34521211 | ||
| Islet cell transplantation tolerance | Q34558458 | ||
| Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens. | Q36352430 | ||
| Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo | Q36353340 | ||
| CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade | Q36369151 | ||
| Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance | Q36401145 | ||
| Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. | Q37382702 | ||
| Skin allograft maintenance in a new synchimeric model system of tolerance | Q37494823 | ||
| Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. | Q40794187 | ||
| Induction of immunologic tolerance for transplantation | Q40827011 | ||
| Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade | Q44023033 | ||
| Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance. | Q44414277 | ||
| NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance induction | Q45043581 | ||
| Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/L | Q54059972 | ||
| Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. | Q54073234 | ||
| NOD mice have a generalized defect in their response to transplantation tolerance induction. | Q54095945 | ||
| Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance | Q56904417 | ||
| Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions | Q56905069 | ||
| Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment | Q56906119 | ||
| Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner | Q56906395 | ||
| P433 | issue | 4 | |
| P921 | main subject | type-1 diabetes | Q124407 |
| P304 | page(s) | 329-335 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Current diabetes report | Q26841965 |
| P1476 | title | Induction of tolerance for islet transplantation for type 1 diabetes | |
| P478 | volume | 3 |
| Q46454884 | CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice |
| Q36485931 | Coinhibitory T-cell signaling in islet allograft rejection and tolerance |
| Q35116303 | Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same? |
| Q37754644 | Dendritic cell-based therapy in Type 1 diabetes mellitus |
| Q37423395 | Effects of preexisting autoimmunity on heart graft prolongation after donor-specific transfusion and anti-CD154. |
| Q36897372 | Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus |
| Q36492596 | Present and future cell therapies for pancreatic beta cell replenishment |
Search more.